Maternova, Inc. and MedMira Inc. announced that the companies have entered into a multinational distribution agreement. Under the agreement, Maternova will have exclusive distribution rights across Latin America and non-exclusive rights in the United States for MedMira's Reveal®, Multiplo® and Miriad® brands that are aimed at reducing HIV, hepatitis, syphilis and other infectious and sexually transmitted diseases. The new partnership increases Maternova's product lines by offering additional unique, quality products, including the Multiplo TP/HIV rapid test that delivers 100% sensitivity in identifying co-infections and is helping to reduce mother-to-child transmission (MTCT) of syphilis and HIV.

In addition, the Reveal G4 HIV rapid test provides the highest sensitivity and specificity as outlined in recent studies conducted by the CDC. All products are exclusively produced in Canada in an FDA- and MDSAP-certified manufacturing facility and conform to all required standards.